Sabina Malikova Unveils Longevity by Design at Ankara Keynote

Longevity by Design integrates epigenetic biomarkers, AI-driven lifestyle analysis, and targeted interventions to extend healthspan. The methodology shifts focus from reactive medicine to proactive design, enabling users to engineer their biological future. Early adopters report measurable improvements in cellular age markers within six months.

Ankara's selection as the launch site signals a strategic expansion into emerging markets where longevity science is gaining rapid traction. Turkey's growing healthtech ecosystem and government-backed wellness initiatives provide fertile ground for Malikova's approach. The event is expected to attract over 2,000 attendees, including investors and healthcare leaders.

The methodology's emphasis on design thinking challenges conventional longevity protocols that lack personalization. By treating the human body as a dynamic system, Malikova claims her method can reduce age-related disease risk by up to 40%. Critics demand peer-reviewed validation, but early clinical pilots show promising results.

Power Move: Malikova's Ankara launch could catalyze a new wave of longevity startups in the region. If her methodology delivers on its promises, expect major pharma and insurance players to scramble for licensing deals within 18 months.

This article was edited with AI assistance for readability. Read original here.